Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

2.78 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 41.3236.97637.61628.038110.751266.55836.2843.06942.55155.14330.57259.71440.80749.1728.99654.95192.55296.01663.6582.422-25.154
Short Term Investments 349.932389.409451.368454.881405.886286.428356.239394.302379.175400.078258.797280.173325.984201.73269.385283.554274.884137.1750050.308
Cash and Short Term Investments 391.252426.385488.984482.919516.637552.986392.519437.371421.726455.221289.369339.887366.791250.9298.381338.505367.436233.19163.6582.42225.154
Net Receivables 000001.7890005.1654.212.6350.1081.481.6630.4170.1220.0730.1390.140
Inventory 00007.4078.2220-7.041-4.212-5.165000.24300000000
Other Current Assets 9.01813.23114.82213.79919.0349.15417.70729.12412.1647.247.7038.00510.6667.0696.3111.1945.1785.2172.221.5050
Total Current Assets 400.27439.616503.806496.718528.264563.929410.226451.933433.89467.626301.282350.77377.565259.449306.354345.104372.736238.48166.00984.06725.154
Non-Current Assets:
Property, Plant & Equipment, Net 38.41938.81140.40541.73542.57743.23444.35550.07850.67351.52352.12452.8395.3913.4463.4093.6192.3962.5712.7952.8360
Goodwill 3.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7360
Intangible Assets 00000000000008.88.88.88.88.88.88.80
Goodwill and Intangible Assets 3.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.7363.73612.53612.53612.53612.53612.53612.53612.5360
Long Term Investments 02.6812.6812.6812.6272.62718.90321.21328.03530.40635.74437.49539.3263.0213.264000000
Tax Assets 0-2.681010.339-2.627-2.627014.1470007.046.042-3.021-3.264000000
Other Non-Current Assets 8.2366.8366.8516.81811.13810.54512.122-1.79712.85914.56512.7912.6273.0215.512.794.2965.5653.6296.2893.218-25.154
Total Non-Current Assets 50.39152.06453.67365.30957.45157.51579.11687.37795.303100.23104.395103.73757.51624.51321.99920.45120.49718.73621.6218.59-25.154
Total Assets 450.661491.68557.479562.027585.715621.444489.342539.31529.193567.856405.677454.507435.081283.962328.353365.555393.233257.21787.629102.6570
Liabilities & Equity:
Current Liabilities:
Account Payables 8.20220.4410.50214.92614.26412.30512.81811.2479.8212.04113.16311.598.0468.2738.3378.6615.4374.2177.0194.2890
Short Term Debt 02.709002.4252.335002.2071.7331.2691.4530.8620.8041.0990.9020.8710.810.810.7810
Tax Payables 00.4250.4030.2810.6540.622000.3480.6940.6970.9710.7670.560.6060.4100000
Deferred Revenue 000.4030.281-2.425-2.335-2.247-2.16200000.7670.560.6060.4100000
Other Current Liabilities 46.67543.11843.89354.1641.57536.49743.5445.441.68634.16828.35629.9329.7423.9422.75518.62817.59810.549.119.8270
Total Current Liabilities 54.87766.69254.79869.36758.91851.75956.35856.64754.06148.63643.48543.94439.41533.57732.79728.60123.90615.56716.93914.8970
Non-Current Liabilities:
Long Term Debt 40.45741.31842.61686.386.53288.05489.54245.166045.07244.97844.4590001.09700000
Deferred Revenue Non-Current 000-00000-0.045-45.072-44.978-44.4590-0.296-0.438-1.097-1.031-1.262-1.48400
Deferred Tax Liabilities Non-Current 00010.339000.7560.8531.2251.3251.5481.6221.672.482.482.482.4632.4632.4632.4630
Other Non-Current Liabilities 0.9961.0891.294-41.37-41.632-41.651-42.9792.6245.16900000.2960.43801.0311.262157.4180.9490
Total Non-Current Liabilities 41.45342.40743.9155.26944.946.40347.31948.63946.39446.39746.52646.0811.672.7762.9183.5773.4943.725159.8814.1630
Total Liabilities 96.33109.09998.708124.636103.81898.162103.677105.286100.45595.03390.01190.02541.08536.35335.71532.17827.419.292176.8219.060
Equity:
Preferred Stock 000000000000.52800024.79500155.934141.70659.83
Common Stock 0.0710.0710.070.070.070.070.0590.0590.0570.0570.0460.0450.0450.0410.0410.0410.0410.0363.2160.0250
Retained Earnings -1,006.923-966.765-878.488-888.556-827.639-772.111-659.584-596.365-541.394-486.993-418.636-359.559-309.5-305.309-250.735-200.834-160.531-125.976-99.119-82.9930
Accumulated Other Comprehensive Income/Loss 1.5940.140.7732.194-0.359-0.338-0.556-1.353-2.27-1.779-1.109-0.1250.0320.0940.050.0360.0230.004-0.205-0.167-35.06
Other Total Stockholders Equity 1,359.5891,349.1351,336.4161,323.5761,309.6961,295.521,045.5681,031.462972.111961.205734.997723.593702.855529.019519.03509.339501.522339.16015.3437.536
Total Shareholders Equity 354.331382.581458.771437.284481.768523.141385.487433.803428.504472.49315.298364.482393.432223.845268.386333.377341.055213.224-95.90376.77632.306
Total Equity 354.331382.581458.771437.391481.897523.282385.665434.024428.738472.823315.666365.01393.996247.609292.638358.172365.833237.925-89.19183.59732.306
Total Liabilities & Shareholders Equity 450.661491.68557.479562.027585.715621.444489.342539.31529.193567.856405.677454.507435.081283.962328.353365.555393.233257.21787.629102.65732.306